What is the equity of Genscript Biotech this year?
Genscript Biotech has equity of 0 USD this year.
Genscript Biotech Equity 2024
Genscript Biotech Equity
0 USD
Ticker
1548.HK
ISIN
KYG3825B1059
WKN
A2ACSB
In 2024, Genscript Biotech's equity was 0 USD, a -100% increase from the 1.01 B USD equity in the previous year.
Genscript Biotech Aktienanalyse
What does Genscript Biotech do?
GenScript Biotech Corp. is a leading biotechnology company founded in Nanjing, China in 2002. Today, it is headquartered in New Jersey, USA and operates worldwide. Genscript Biotech ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Genscript Biotech's Equity
Genscript Biotech's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Genscript Biotech's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Genscript Biotech's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Genscript Biotech's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Genscript Biotech’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Genscript Biotech Stock
What was the equity of Genscript Biotech compared to the previous year?
The equity of Genscript Biotech has increased/decreased by -100% decreased compared to the previous year.
What impact does a high equity have on investors of Genscript Biotech?
A high equity is advantageous for investors of Genscript Biotech as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Genscript Biotech?
A low equity can be a risk for investors of Genscript Biotech, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Genscript Biotech affect the company?
An increase in equity of Genscript Biotech can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Genscript Biotech affect the company?
A reduction in equity of Genscript Biotech can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Genscript Biotech?
Some factors that can affect the equity of Genscript Biotech include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Genscript Biotech so important for investors?
The equity of Genscript Biotech is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Genscript Biotech take to change the equity?
To change equity, Genscript Biotech can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Genscript Biotech pay?
Over the past 12 months, Genscript Biotech paid a dividend of 0.01 USD . This corresponds to a dividend yield of about 1.13 %. For the coming 12 months, Genscript Biotech is expected to pay a dividend of 0 USD.
What is the dividend yield of Genscript Biotech?
The current dividend yield of Genscript Biotech is 1.13 %.
When does Genscript Biotech pay dividends?
Genscript Biotech pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Genscript Biotech?
Genscript Biotech paid dividends every year for the past 3 years.
What is the dividend of Genscript Biotech?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Genscript Biotech located?
Genscript Biotech is assigned to the 'Health' sector.
Wann musste ich die Aktien von Genscript Biotech kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Genscript Biotech from 6/21/2017 amounting to 0.012 USD, you needed to have the stock in your portfolio before the ex-date on 6/5/2017.
When did Genscript Biotech pay the last dividend?
The last dividend was paid out on 6/21/2017.
What was the dividend of Genscript Biotech in the year 2023?
In the year 2023, Genscript Biotech distributed 0 USD as dividends.
In which currency does Genscript Biotech pay out the dividend?
The dividends of Genscript Biotech are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Genscript Biotech
Our stock analysis for Genscript Biotech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Genscript Biotech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Genscript Biotech Revenue
- Genscript Biotech Net Income
- Genscript Biotech P/E
- Genscript Biotech P/S
- Genscript Biotech EBIT
- Genscript Biotech Dividend
- Genscript Biotech Stocks
- Genscript Biotech Market capitalization
- Genscript Biotech Debt
- Genscript Biotech Liabilities
- Genscript Biotech Equity
- Genscript Biotech AAQS
- Genscript Biotech Employees
- Genscript Biotech ROE
- Genscript Biotech ROA
- Genscript Biotech ROCE
